ATP: No. 1 Carlos Alcaraz (leg) withdraws from Australian Open

Date:

Share post:


World No. 1 and reigning U.S. Open champion Carlos Alcaraz said a leg injury will keep him from competing in the upcoming Australian Open.

The 19-year-old Spaniard posted the news to social media on Friday. He also pulled out of a scheduled tune-up event.

“I’d worked so hard to get to my best level for Australia but unfortunately I won’t be able to play the Care A2+ Kooyong or the Australian Open,” he posted. “It’s tough, but I have to be optimistic, recover and look forward. See you in 2024 @AustralianOpen.”

Alcaraz blamed the injury on a “chance, unnatural movement in training.” He said the semimembranosus muscle — the largest hamstring muscle — of his right leg is impacted.

Alcaraz has six career tour titles — five of them coming in 2022. In addition to the U.S. Open, he won ATP Masters 1000 events in Madrid and Miami, as well as clay-court tournaments in Barcelona and Rio de Janeiro.

His countryman and boyhood idol, Rafael Nadal, is ranked No. 2 in the world. He is the defending champion at the Australian Open.

The Australian Open draw is scheduled for Thursday, with the Grand Slam event set for Jan. 16-29 in Melbourne.

–Field Level Media

spot_img

Related articles

ATP: Jannik Sinner, Italy beat Netherlands to win 2nd straight Davis Cup

World No. 1 Jannik Sinner defeated Tallon Griekspoor to deliver Italy the 2024 Davis Cup title over the...

ATP: Italy ousts Australia in Davis Cup semis, eyes second straight title

World No. 1 Jannik Sinner clinched defending Davis Cup champion Italy's return to the final in Saturday's 2-0...

ATP: Rivals turned teammates: Andy Murray to coach Novak Djokovic

Novak Djokovic has hired a new coach -- longtime friend and rival Andy Murray, who retired from competitive...

ATP: Netherlands qualifies for first Davis Cup final by beating Germany

The Netherlands will play for the Davis Cup title after completing a 2-0 sweep of Germany in the...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.